nodes	percent_of_prediction	percent_of_DWPC	metapath
Astemizole—ABCB1—ovarian cancer	0.379	1	CbGaD
Astemizole—CYP3A7—Paclitaxel—ovarian cancer	0.0588	0.0991	CbGbCtD
Astemizole—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0588	0.0991	CbGbCtD
Astemizole—ABCB1—Topotecan—ovarian cancer	0.058	0.0977	CbGbCtD
Astemizole—CYP3A5—Paclitaxel—ovarian cancer	0.0441	0.0743	CbGbCtD
Astemizole—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0425	0.0716	CbGbCtD
Astemizole—CYP3A7—Docetaxel—ovarian cancer	0.0425	0.0716	CbGbCtD
Astemizole—ABCB1—Vinorelbine—ovarian cancer	0.0409	0.0688	CbGbCtD
Astemizole—CYP2D6—Vinorelbine—ovarian cancer	0.0385	0.0649	CbGbCtD
Astemizole—CYP3A4—Topotecan—ovarian cancer	0.0348	0.0585	CbGbCtD
Astemizole—CYP3A5—Docetaxel—ovarian cancer	0.0319	0.0537	CbGbCtD
Astemizole—ABCB1—Paclitaxel—ovarian cancer	0.0287	0.0484	CbGbCtD
Astemizole—CYP3A4—Vinorelbine—ovarian cancer	0.0245	0.0412	CbGbCtD
Astemizole—ABCB1—Docetaxel—ovarian cancer	0.0208	0.035	CbGbCtD
Astemizole—CYP3A4—Paclitaxel—ovarian cancer	0.0172	0.029	CbGbCtD
Astemizole—ABCB1—Doxorubicin—ovarian cancer	0.0155	0.0261	CbGbCtD
Astemizole—CYP2D6—Doxorubicin—ovarian cancer	0.0146	0.0246	CbGbCtD
Astemizole—CYP3A4—Docetaxel—ovarian cancer	0.0124	0.0209	CbGbCtD
Astemizole—CYP3A4—Doxorubicin—ovarian cancer	0.00928	0.0156	CbGbCtD
Astemizole—CYP2J2—endometrium—ovarian cancer	0.00175	0.0658	CbGeAlD
Astemizole—CYP2J2—uterus—ovarian cancer	0.00161	0.0606	CbGeAlD
Astemizole—CYP2J2—female reproductive system—ovarian cancer	0.00145	0.0545	CbGeAlD
Astemizole—CYP2J2—vagina—ovarian cancer	0.00131	0.0493	CbGeAlD
Astemizole—CYP2J2—testis—ovarian cancer	0.00117	0.044	CbGeAlD
Astemizole—KCNH2—myometrium—ovarian cancer	0.00106	0.0398	CbGeAlD
Astemizole—HRH1—myometrium—ovarian cancer	0.000847	0.0319	CbGeAlD
Astemizole—KCNH2—uterine cervix—ovarian cancer	0.000822	0.031	CbGeAlD
Astemizole—KCNH2—endometrium—ovarian cancer	0.000744	0.028	CbGeAlD
Astemizole—KCNH2—uterus—ovarian cancer	0.000685	0.0258	CbGeAlD
Astemizole—CYP3A5—uterine cervix—ovarian cancer	0.000679	0.0256	CbGeAlD
Astemizole—HRH1—epithelium—ovarian cancer	0.000665	0.0251	CbGeAlD
Astemizole—HRH1—uterine cervix—ovarian cancer	0.000659	0.0248	CbGeAlD
Astemizole—HRH1—decidua—ovarian cancer	0.000628	0.0237	CbGeAlD
Astemizole—KCNH2—female reproductive system—ovarian cancer	0.000616	0.0232	CbGeAlD
Astemizole—HRH1—endometrium—ovarian cancer	0.000596	0.0225	CbGeAlD
Astemizole—KCNH2—bone marrow—ovarian cancer	0.000582	0.0219	CbGeAlD
Astemizole—KCNH2—female gonad—ovarian cancer	0.000561	0.0211	CbGeAlD
Astemizole—KCNH2—vagina—ovarian cancer	0.000557	0.021	CbGeAlD
Astemizole—KCNH2—testis—ovarian cancer	0.000497	0.0187	CbGeAlD
Astemizole—HRH1—female reproductive system—ovarian cancer	0.000494	0.0186	CbGeAlD
Astemizole—ABCB1—myometrium—ovarian cancer	0.000464	0.0175	CbGeAlD
Astemizole—CYP3A5—female gonad—ovarian cancer	0.000463	0.0175	CbGeAlD
Astemizole—CYP3A5—vagina—ovarian cancer	0.00046	0.0173	CbGeAlD
Astemizole—HRH1—female gonad—ovarian cancer	0.000449	0.0169	CbGeAlD
Astemizole—HRH1—vagina—ovarian cancer	0.000447	0.0168	CbGeAlD
Astemizole—ABCB1—embryo—ovarian cancer	0.000446	0.0168	CbGeAlD
Astemizole—HRH1—testis—ovarian cancer	0.000399	0.015	CbGeAlD
Astemizole—CYP3A4—female reproductive system—ovarian cancer	0.000382	0.0144	CbGeAlD
Astemizole—CYP2D6—female reproductive system—ovarian cancer	0.000376	0.0142	CbGeAlD
Astemizole—ABCB1—epithelium—ovarian cancer	0.000364	0.0137	CbGeAlD
Astemizole—ABCB1—uterine cervix—ovarian cancer	0.000361	0.0136	CbGeAlD
Astemizole—KCNH2—lymph node—ovarian cancer	0.00036	0.0136	CbGeAlD
Astemizole—ABCB1—decidua—ovarian cancer	0.000344	0.013	CbGeAlD
Astemizole—CYP2D6—female gonad—ovarian cancer	0.000342	0.0129	CbGeAlD
Astemizole—ABCB1—endometrium—ovarian cancer	0.000326	0.0123	CbGeAlD
Astemizole—CYP2D6—testis—ovarian cancer	0.000303	0.0114	CbGeAlD
Astemizole—ABCB1—gonad—ovarian cancer	0.000303	0.0114	CbGeAlD
Astemizole—ABCB1—uterus—ovarian cancer	0.000301	0.0113	CbGeAlD
Astemizole—HRH1—lymph node—ovarian cancer	0.000289	0.0109	CbGeAlD
Astemizole—ABCB1—female reproductive system—ovarian cancer	0.00027	0.0102	CbGeAlD
Astemizole—ABCB1—bone marrow—ovarian cancer	0.000255	0.00962	CbGeAlD
Astemizole—ABCB1—female gonad—ovarian cancer	0.000246	0.00927	CbGeAlD
Astemizole—ABCB1—vagina—ovarian cancer	0.000244	0.00921	CbGeAlD
Astemizole—ABCB1—testis—ovarian cancer	0.000218	0.00822	CbGeAlD
Astemizole—ABCB1—lymph node—ovarian cancer	0.000158	0.00596	CbGeAlD
